Inactivated vaccines represent 46.3% of the product type category and bacterial diseases account for 58.6% of application demand in 2026. The anti-infective vaccines market was valued at USD 64.3 billion in 2025, is projected to reach USD 219.4 billion by 2036 and is forecast to post an 11.8% CAGR between 2026 and 2036.